Q32 Bio Inc.
QTTBCIK 0001661998 · Pharmaceutical Preparations · Nasdaq
- Q32 Bio Inc. (until 2026-06-16)
- Homology Medicines, Inc. (until 2024-03-22)
Revenue (TTM)
$1.96M
−64.0% YoY
Q1 May 2026
Net Income (TTM)
−$35.52M
+162.5% YoY
Q1 May 2026
EPS Diluted (TTM)
−$2.82
+136.8% YoY
Q1 May 2026
Gross Margin
—
Q1 May 2026
Operating Margin
-1,874.3%
Q1 May 2026
Net Margin
-1,814.0%
Q1 May 2026
Free Cash Flow (TTM)
−$47.84M
Q1 May 2026
Cash
$50.75M
Q1 May 2026
Total Debt
—
Q1 May 2026
Shares Outstanding
16.96M sh
Q1 May 2026